Research offers new insights into malaria parasite

May 18, 2018

RIVERSIDE, Calif. (http://www.ucr.edu) - A team of researchers led by a University of California, Riverside, scientist has found that various stages of the development of human malaria parasites, including stages involved in malaria transmission, are linked to epigenetic features and how chromatin -- the complex of DNA and proteins within the nucleus -- is organized and structured in these parasites.

"Our results provide insights into the connection between genome organization, epigenetic features, and stage-specific gene expression in the malaria parasite," said Karine Le Roch, a professor of molecular, cell, and systems biology, who led the analysis of the genome organization of two kinds of human malaria parasites. "Proteins that are known to control these features could be identified as new targets for novel therapeutic strategies. By disrupting these proteins, we could disrupt the chromatin structure, and thus disrupt the life cycle progression of the parasite -- ultimately controlling the spread of malaria."

The development of the malaria parasite throughout its life cycle is mostly controlled by how the chromatin structure, together with epigenetics, modulates gene expression. Epigenetics involves genetic control by factors other than an individual's DNA sequence. By switching genes on or off, epigenetic changes determine which genes are transcribed.

"We also found that the epigenetic features are essential and connected with transcriptional activity of several parasite-specific gene families, such as those involved in pathogenesis, liver cell invasion, and regulation of sexual differentiation," Le Roch said.

Study results appear this week in Nature Communications.

Le Roch and her colleagues demonstrated that genome organization is not only important in human tissues and complex organisms, but can also affect the normal development of eukaryotic pathogens, such as malaria parasites.

Malaria, which infects hundreds of millions of people worldwide and kills more than 450,000 people each year, is caused by one of five parasites of the Plasmodium species. Understanding the mechanisms involved in gene regulation during the various life cycle stages of the parasites is important for developing novel strategies to block parasite replication and transmission.

Le Roch and her colleagues analyzed the genome organization when the parasite replicates inside red blood cells and during sexual differentiation in P. falciparum, as well as during the transmission stage from mosquito to humans in P. falciparum and P. vivax. P. falciparum is the most common and deadly parasite. P. vivax, responsible for significant disease, is found mostly in Southeast Asia. Understanding how the transitions between the various life cycle stages of the parasites are regulated remains an important goal in malaria research.

The researchers used next-generation sequencing at UCR to understand the epigenetics features and how the Plasmodium chromatin is organized throughout the parasite's life cycle.

"The sequencing showed us how the Plasmodium genome is organized," said Le Roch, who directs the Center for Infectious Disease and Vector Research at UCR. "We observed that genes that are stage-specific and important in pathogenesis are close to each other. When they are not needed, they cluster together in a repressive center in the parasite nucleus. When they are needed, the chromatin opens up and genes move away from the repressive center."

The findings bring a new level of insight into genome organization and dynamics during the Plasmodium life cycle, the authors argue, and open up new avenues for targeted approaches toward understanding parasite gene regulation.

"Molecules inhibiting the restructuring of the genome throughout the life cycles have the potential to act as potent antimalarials," Le Roch said. "Understanding the genetic and epigenetic elements that control parasite development, including the stages that are responsible for transmission of the disease, is key to the ultimate development of new therapeutic and transmission blocking strategies."

Le Roch, a member of UCR's Institute for Integrative Genome Biology, recently received a five-year, $3.2 million grant from the National Institutes of Health to continue her work on the chromatin structure in Plasmodium.

"This generous grant will allow us to develop state-of-the-art approaches to characterize proteins and molecular components that regulate the gene expression and 3D genome architecture of P. falciparum throughout its life cycle," she said. "We expect our new study will offer fresh insights into the biology of the parasite and help us identify novel targets to kill the parasite."
-end-
Le Roch's coauthors on the paper are Evelien M. Bunnik (first author); Gayani Batugedara, Jacques Prudhomme, and Anthony Cort of UCR; Kate B. Cook and William Stafford Noble of the University of Washington; Nelle Varoquaux of UC Berkeley; Lirong Shi and Photini Sinnis of Johns Hopkins Bloomberg School of Public Health; Chiara Andolina and Francois Nosten of the University of Oxford; Leila S. Ross and David A. Fidock of Columbia University Medical Center; Declan Brady and Rita Tewari of the University of Nottingham; Ferhat Ay of La Jolla Institute for Allergy & Immunology; and Jean-Phillippe Vert of PSL Research University.

The research was supported by grants from the National Institutes of Health, the Human Frontier Science Program, and others.

The University of California, Riverside is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment is now nearly 23,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of more than $1 billion.

University of California - Riverside

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.